Technical corrections only. v3 updates the name of the Clerk attesting to the bill's passage in the House and includes metadata regarding its referral to the Senate. No substantive policy changes were made to the bill's text.
Stop Chinese Fentanyl Act of 2025
- Sponsor
- Rep. Barr, Andy [R-KY-6]
- Committees
- Judiciary Committee (primary)
- Last action
- Sep 3, 2025
Bottom line
The "Stop Chinese Fentanyl Act of 2025" aims to strengthen U.S. sanctions against Chinese entities and officials involved in fentanyl trafficking by expanding existing definitions and enhancing oversight of emergency economic powers used for drug trafficking.
What it actually does
This bill expands the definition of "foreign opioid trafficker" under the Fentanyl Sanctions Act to specifically include Chinese entities involved in producing or distributing synthetic opioids and precursors, as well as senior Chinese officials who aid such trafficking through intentional inaction. It also mandates annual evaluations of national emergencies related to international drug trafficking under the International Emergency Economic Powers Act (IEEPA) and requires the President to consider costs, benefits, and termination criteria when issuing regulations under IEEPA for such emergencies.
Proponents argue
Supporters argue this bill is a critical step to combat the fentanyl crisis by directly targeting the source of illicit synthetic opioids and their precursors in China. They contend that strengthening sanctions and holding Chinese officials accountable will pressure the Chinese government to take more decisive action against trafficking networks, thereby reducing the flow of fentanyl into the United States and saving lives.
Opponents contend
Critics might argue that while the intent is laudable, this bill could escalate diplomatic tensions with China without guaranteeing a significant reduction in fentanyl flow, as illicit networks are adaptable. Some may also raise concerns that expanding the definition of "foreign opioid trafficker" to include senior officials based on "intentional inaction" could be overly broad or difficult to prove, potentially leading to unintended geopolitical consequences or retaliatory measures.
The bill is relatively short and straightforward, making it accessible for a quick read and evaluation by an informed citizen.
Section 2
Calls for PRC Cooperation on Precursor Chemicals
This section expresses Congress's view that the Chinese government should collaborate with the U.S. to identify unregulated precursor chemicals, ensure proper labeling of chemical shipments, implement "know-your-customer" procedures for chemical sales, and establish and enforce new rules to combat precursor trafficking through its relevant agencies.
Supporters argue
Supporters argue that a clear statement of congressional expectations can provide diplomatic leverage and signal the seriousness with which the U.S. views China's role in the fentanyl crisis, encouraging greater cooperation.
Critics contend
Some might argue that a "Sense of Congress" is largely symbolic and lacks enforcement power, potentially being ignored by the PRC without concrete legal obligations.
Tradeoffs
Balances diplomatic signaling with the lack of direct legal enforceability.
Section 3(a)
Includes Chinese Entities and Officials in Sanctions Definition
This amendment expands the definition of "foreign opioid trafficker" under the Fentanyl Sanctions Act to explicitly include any Chinese entity that produces, manufactures, distributes, sells, finances, or transports synthetic opioids or precursors and fails to take credible steps to prevent trafficking. It also includes senior Chinese officials with regulatory or law enforcement responsibilities who aid trafficking through intentional inaction.
Section 3(b)
Mandates Scrutiny of Key Chinese Officials and Extends Reporting Period
This provision amends the Fentanyl Sanctions Act to require the President to specifically consider whether the heads of China's National Narcotics Control Commission, Ministry of Public Security, General Administration of Customs, and National Medical Products Administration are foreign opioid traffickers. It also extends the period for identifying foreign opioid traffickers from 5 years to 10 years.
Section 4(a)
Requires Annual Review of Drug Trafficking National Emergencies
This amendment to the International Emergency Economic Powers Act (IEEPA) requires the President to transmit annual written evaluations to Congress for any covered national emergency related to international drug trafficking that has been declared within the preceding 5 years and is still active. These evaluations must assess effectiveness, consider stakeholder views, and discuss potential changes.
Section 4(b)(3)
Mandates Cost-Benefit Analysis and Termination Criteria for IEEPA Regulations
This amendment requires the President, when issuing regulations under IEEPA pursuant to a covered national emergency, to consider the costs and benefits of alternatives, evaluate them for expeditious resolution of the emergency, establish criteria for termination, and include explanations of how regulations will resolve the emergency and discuss costs/benefits in their basis and purpose.
Section 5
Sanctions Exemption for Goods Importation
This section explicitly states that the authority and requirements to impose sanctions under this Act do not include the authority or requirement to impose sanctions on the importation of goods. "Good" is defined broadly to include any article, substance, material, supply, or manufactured product, excluding technical data.
Requires the President, when issuing IEEPA regulations for covered national emergencies (like drug trafficking), to consider costs/benefits, evaluate for expeditious resolution, establish termination criteria, and explain these in the regulations' basis and purpose.
Section 4(b)(3)
Why it matters:This is standard legislative practice for amending existing statutes, but its significance for executive branch accountability might be overlooked by a casual reader focused on the sanctions.
Case for: Ensures greater transparency, accountability, and strategic planning in the use of emergency economic powers, preventing open-ended or poorly justified executive actions.
Case against: Could introduce bureaucratic hurdles and slow down the executive's ability to respond rapidly and flexibly to evolving national security threats, including drug trafficking.
Estimated impact: Increases administrative burden and transparency requirements for the Executive Branch when declaring and managing IEEPA-based national emergencies related to drug trafficking.